378 related articles for article (PubMed ID: 25428709)
21. The Efficacy of Psychological Therapies in Reducing Weight and Binge Eating in People with Bulimia Nervosa and Binge Eating Disorder Who Are Overweight or Obese-A Critical Synthesis and Meta-Analyses.
Palavras MA; Hay P; Filho CA; Claudino A
Nutrients; 2017 Mar; 9(3):. PubMed ID: 28304341
[TBL] [Abstract][Full Text] [Related]
22. The neurobiological basis of binge-eating disorder.
Kessler RM; Hutson PH; Herman BK; Potenza MN
Neurosci Biobehav Rev; 2016 Apr; 63():223-38. PubMed ID: 26850211
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic options for binge eating disorder.
Ramacciotti CE; Coli E; Marazziti D; Segura-García C; Brambilla F; Piccinni A; Dell'osso L
Eat Weight Disord; 2013 Mar; 18(1):3-9. PubMed ID: 23757245
[TBL] [Abstract][Full Text] [Related]
24. Managing comorbid obesity and depression through clinical pharmacotherapies.
McElroy SL; Guerdjikova AI; Mori N; Keck PE
Expert Opin Pharmacother; 2016 Aug; 17(12):1599-610. PubMed ID: 27280311
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological interventions for binge eating: lessons from animal models, current treatments, and future directions.
Berner LA; Bocarsly ME; Hoebel BG; Avena NM
Curr Pharm Des; 2011; 17(12):1180-7. PubMed ID: 21492094
[TBL] [Abstract][Full Text] [Related]
26. An Innovative Disease-Drug-Trial Framework to Guide Binge Eating Disorder Drug Development: A Case Study for Topiramate.
Kalaria SN; McElroy SL; Gobburu J; Gopalakrishnan M
Clin Transl Sci; 2020 Jan; 13(1):88-97. PubMed ID: 31386273
[TBL] [Abstract][Full Text] [Related]
27. Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology.
Heal DJ; Smith SL
J Psychopharmacol; 2022 Jun; 36(6):680-703. PubMed ID: 34318734
[TBL] [Abstract][Full Text] [Related]
28. Latest advancements in the pharmacological treatment of binge eating disorder.
Marazziti D; Corsi M; Baroni S; Consoli G; Catena-Dell'Osso M
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(15):2102-7. PubMed ID: 23280026
[TBL] [Abstract][Full Text] [Related]
29. Management of eating disorders.
Berkman ND; Bulik CM; Brownley KA; Lohr KN; Sedway JA; Rooks A; Gartlehner G
Evid Rep Technol Assess (Full Rep); 2006 Apr; (135):1-166. PubMed ID: 17628126
[TBL] [Abstract][Full Text] [Related]
30. A double-blind, randomized pilot trial of chromium picolinate for binge eating disorder: results of the Binge Eating and Chromium (BEACh) study.
Brownley KA; Von Holle A; Hamer RM; La Via M; Bulik CM
J Psychosom Res; 2013 Jul; 75(1):36-42. PubMed ID: 23751236
[TBL] [Abstract][Full Text] [Related]
31. GABAergic and glutamatergic modulation in binge eating: therapeutic approach.
Guardia D; Rolland B; Karila L; Cottencin O
Curr Pharm Des; 2011; 17(14):1396-409. PubMed ID: 21524265
[TBL] [Abstract][Full Text] [Related]
32. What pharmacological interventions are effective in binge-eating disorder? Insights from a critical evaluation of the evidence from clinical trials.
Heal DJ; Gosden J
Int J Obes (Lond); 2022 Apr; 46(4):677-695. PubMed ID: 34992243
[TBL] [Abstract][Full Text] [Related]
33. Comparing cognitive behavioural therapy for eating disorders integrated with behavioural weight loss therapy to cognitive behavioural therapy-enhanced alone in overweight or obese people with bulimia nervosa or binge eating disorder: study protocol for a randomised controlled trial.
Palavras MA; Hay P; Touyz S; Sainsbury A; da Luz F; Swinbourne J; Estella NM; Claudino A
Trials; 2015 Dec; 16():578. PubMed ID: 26683478
[TBL] [Abstract][Full Text] [Related]
34. Loss of control is central to psychological disturbance associated with binge eating disorder.
Colles SL; Dixon JB; O'Brien PE
Obesity (Silver Spring); 2008 Mar; 16(3):608-14. PubMed ID: 18239550
[TBL] [Abstract][Full Text] [Related]
35. Binge-eating disorder: Clinical and therapeutic advances.
Hutson PH; Balodis IM; Potenza MN
Pharmacol Ther; 2018 Feb; 182():15-27. PubMed ID: 28830840
[TBL] [Abstract][Full Text] [Related]
36. A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder.
McElroy SL; Guerdjikova AI; Blom TJ; Crow SJ; Memisoglu A; Silverman BL; Ehrich EW
Int J Eat Disord; 2013 Apr; 46(3):239-45. PubMed ID: 23381803
[TBL] [Abstract][Full Text] [Related]
37. Antidepressants compared to placebo for people with binge eating disorder: A systematic review and meta-analysis.
Sioziou AL; Lappas AS; Skarlatos M; Mesiari C; Florou MC; Argyrou A; Christodoulou N; Chourdakis M; Samara M
Eur Neuropsychopharmacol; 2024 Jul; 84():5-15. PubMed ID: 38642437
[TBL] [Abstract][Full Text] [Related]
38. An open-label trial on the efficacy and tolerability of naltrexone/bupropion SR for treating altered eating behaviours and weight loss in binge eating disorder.
Carbone EA; Caroleo M; Rania M; Calabrò G; Staltari FA; de Filippis R; Aloi M; Condoleo F; Arturi F; Segura-Garcia C
Eat Weight Disord; 2021 Apr; 26(3):779-788. PubMed ID: 32356145
[TBL] [Abstract][Full Text] [Related]
39. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders.
Aigner M; Treasure J; Kaye W; Kasper S;
World J Biol Psychiatry; 2011 Sep; 12(6):400-43. PubMed ID: 21961502
[TBL] [Abstract][Full Text] [Related]
40. [Binge eating disorder].
de Zwaan M; Friederich HC
Ther Umsch; 2006 Aug; 63(8):529-33. PubMed ID: 16941397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
